MedTrace Logo

Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)

NCT03035344 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2017-01-30

No results posted yet for this study

Summary

Study of the intermediate metabolism in children diagnosed with ALL compared to healthy matched controls.

Conditions

  • Acute Lymphoblastic Leukemia, Pediatric
  • Metabolism Disorder

Interventions

OTHER

Metabolome study

Metabolome study in ALL patients compared to healthy controls

Sponsors & Collaborators

  • Aristotle University Of Thessaloniki

    lead OTHER

Principal Investigators

  • Athanassios Evangeliou, Prof · Aristotle University Of Thessaloniki

Eligibility

Min Age
1 Month
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-05-31
Completion
2018-11-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03035344 on ClinicalTrials.gov